微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 1.52% | -38.21% | -71.64% | 57/140 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | 5.36% | 277.46% | -14.24% | 53/140 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 6.25% | 24.75% | 47.06% | 41/140 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 4.25% | 2.41% | 72.76% | 38/140 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 2.46% | -17.45% | 73.24% | 34/140 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 1.42% | -80.68% | -71.66% | 89/140 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 5.01% | -43.33% | 20.72% | 56/140 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 4.15% | -30.95% | 39.26% | 48/140 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 2.98% | -22.8% | -59.46% | 26/140 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 7.35% | -57.04% | -16.86% | 57/140 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 8.84% | -41.22% | 47.09% | 35/140 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 6.01% | -43.57% | 55.7% | 36/140 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 3.86% | -17.52% | -77.44% | 29/140 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | 17.11% | -0.93% | 13.76% | 36/140 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 15.04% | -15.03% | 41.22% | 33/140 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 10.65% | -32.81% | 127.56% | 31/140 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 4.68% | -33.9% | -72.9% | 34/140 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 17.27% | 4.29% | -2.43% | 48/140 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 17.7% | -24.36% | 11.67% | 32/140 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 15.85% | 14.77% | 123.87% | 22/140 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 7.08% | 42.45% | -57.25% | 22/140 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 16.56% | -8% | -29.23% | 61/140 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 23.4% | 0.21% | 69.44% | 20/140 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 13.81% | 2.45% | 177.87% | 33/140 | 15.17% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 4.97% | -44.03% | -72.39% | 19/140 | 3.31% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 18% | 9.22% | -22.91% | 45/140 | 14.66% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 23.35% | 32.29% | 73.22% | 5/140 | 10.54% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 13.48% | 29% | 51.8% | 10/140 | 6.76% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 8.88% | 95.16% | -46.12% | 2/140 | 2.73% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 16.48% | 14.52% | -6.63% | 47/140 | 14.23% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 17.65% | 39.53% | 68.9% | 6/140 | 9.71% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 10.45% | 21.79% | 129.67% | 7/140 | 4.54% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 4.55% | 10.71% | -68.38% | 10/140 | 2.78% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 14.39% | 0.28% | 13.75% | 46/140 | 14.51% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 12.65% | 7.29% | 47.44% | 14/140 | 9.49% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 8.58% | 8.75% | 108.76% | 15/140 | 6.11% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 4.11% | 13.85% | -71.36% | 6/140 | 2.74% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 14.35% | -5.96% | 21.71% | 38/140 | 16.44% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 11.79% | -2.08% | 49.43% | 9/140 | 8.86% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 7.89% | -5.85% | 118.56% | 15/140 | 6.35% | *ST明德 | 23.29% | 行业排名> |
| 2016-03-31 | 3.61% | -8.14% | -76.34% | 6/140 | 2.3% | 健帆生物 | 7.75% | 行业排名> |